Aaron Chamberlain

Aaron Chamberlain is the Chief Science Officer at Object Pharma, Inc. since September 2018. Prior to their current role, Aaron worked as a Vice President - Research at the same company. Before their time at Object Pharma, Inc., Aaron held positions such as Research Fellow at Takeda California, Principal Research Scientist at Takeda California, Senior Research Scientist at Lilly - Applied Molecular Evolution, and Lead Scientist at Xencor Inc. Aaron's educational background includes a PHD in Biochemistry from the University of California, Berkeley.